0.80 USD
▲-0.25+5.62%
盘后 0.74 -1.69%
2026-08-03
市值
$12.56M
市盈率
—
EPS
-1.27
股息率
—
52 周区间
0.46 – 7.20
成交量
197.96K
Beta
1.20
目标价
10.50
52W 低 0.4652W 高 7.20
价格走势
公司简介
CalciMedica, Inc., a clinical-stage biopharmaceutical company, develops therapeutics for illnesses caused by inflammatory and immunologic processes and direct cellular damage. Its lead product candidate comprises Auxora, an intravenous formulated small molecule calcium release-activated calcium (CRAC) channel inhibitors for the treatment of acute pancreatitis, asparaginase-induced pancreatic toxicity, and acute kidney injury, as well as severe COVID-19 pneumonia. The company also develops Auxora for the treatment of ulcerative colitis, traumati...